"Meridian's Binghamton, NY, location conducts research for a broad range of investigational treatments. For example, studies at this site explore vaccines and medicines developed to treat migraines, diabetes, acne, depression, high cholesterol, and other conditions. UHS partners with Meridian Clinical Research to run clinical studies to help develop better treatments for existing patients, and for people worldwide."

During the past decade, Meridian Clinical Research, LLC conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 3 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 3 clinical trials were completed. i.e. 15% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meridian Clinical Research, LLC" #1 sponsor was "ModernaTX, Inc." with 7 trials, followed by "Pfizer" with 5 trials sponsored, "BioNTech SE" with 3 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meridian Clinical Research, LLC" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Meridian Clinical Research, LLC" are "SARS-CoV-2" (4 trials), "COVID-19" (2 trials), "Pneumococcal Disease" (2 trials), "SARS-CoV-2 Infection" (2 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Meridian Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Meridian Clinical Research, LLC" are "Biological" (18 trials), "Other" (6 trials), "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "mRNA-1273" (3 trials), "BNT162b2" (2 trials), "Saline" (2 trials) and "mRNA-1273.214" (2 trials). Other intervention names were less common.

The vast majority of trials in "Meridian Clinical Research, LLC" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Meridian Clinical Research, LLC". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Meridian Clinical Research, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Meridian Clinical Research, LLC, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".